Lack of interaction of the fluorosurfactant C6O4 with human renal transporters: In vitro/in silico analysis.


Journal

Toxicology
ISSN: 1879-3185
Titre abrégé: Toxicology
Pays: Ireland
ID NLM: 0361055

Informations de publication

Date de publication:
30 06 2022
Historique:
received: 01 06 2022
revised: 22 06 2022
accepted: 10 07 2022
pubmed: 15 7 2022
medline: 27 7 2022
entrez: 14 7 2022
Statut: ppublish

Résumé

C6O4 is a water soluble perfluoroether carboxylic acid ammonium salt used as surfactant in the synthesis of fluoropolymers. Available experimental data in rats exposed by the oral route indicate it is eliminated in urine. Previous studies with various linear perfluorocarboxylic acids have suggested that these compounds are substrates of renal membrane transporters in rats and humans, and that the interaction with basal and apical membrane transporters can influence the elimination kinetic by these organisms and explain, in part, the observed differences in the respective half-lives. In particular, apical transporters may contribute to the reuptake of these exogenous compounds from the tubule lumen. The present study was designed to investigate the uptake of C6O4 in two renal cell lines transiently transfected with the human apical membrane transporters, organic anion transporter 4 (OAT4), and urate transporter 1 (URAT1). The uptake of the linear perfluorohexanoic acid (PFC6) was evaluated in parallel. While the uptake of the conjugated steroid estrone-3-sulfate (E3S), a known substrate for renal transporters, and of PFC6 was clearly observed in both cell types transfected with either OAT4 or URAT1, no significant uptake of C6O4 was measured under the same test conditions. The results of the transporter's functionality measured in vitro were consistent with molecular docking simulations. Both outward and inward models of the transporters showed a reduced interaction between C6O4 and URAT1 or OAT4. In contrast, more stable interactions were predicted for PFC6 and PFOA, as well as for the E3S substrate, as shown by the respective docking scores reflecting the binding strength and by the poses assumed in the transporter channels. Altogether, the in vitro and in silico modeling results showed a low reuptake potential and limited interactions of C6O4 molecule with two human apical membrane transporters, contrasting with the more efficient reuptake of PFC6 from the tubule lumen. These results suggest reabsorption from the proximal tubule by apical renal transporters is not likely to interfere with the elimination pathway of C6O4 in humans.

Identifiants

pubmed: 35835357
pii: S0300-483X(22)00169-X
doi: 10.1016/j.tox.2022.153257
pii:
doi:

Substances chimiques

Membrane Transport Proteins 0
Organic Anion Transporters 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

153257

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.

Auteurs

Stefania Bruno (S)

Laboratory of Translational Research, Department of Medical Sciences, University of Torino, Corso Dogliotti 14, 10126 Torino, Italy; Molecular Biotechnology Center, University of Torino, Via Nizza 52, 10126 Torino, Italy. Electronic address: stefania.bruno@unito.it.

Matteo Bersani (M)

Department of Drug Science and Technology, University of Torino, Via Giuria 9, 10125 Torino, Italy.

Serena Astore (S)

Laboratory of Translational Research, Department of Medical Sciences, University of Torino, Corso Dogliotti 14, 10126 Torino, Italy.

Giulia Chiabotto (G)

Laboratory of Translational Research, Department of Medical Sciences, University of Torino, Corso Dogliotti 14, 10126 Torino, Italy.

Alessandro Barge (A)

Department of Drug Science and Technology, University of Torino, Via Giuria 9, 10125 Torino, Italy.

Arianna Binello (A)

Department of Drug Science and Technology, University of Torino, Via Giuria 9, 10125 Torino, Italy.

Francesca Spyrakis (F)

Department of Drug Science and Technology, University of Torino, Via Giuria 9, 10125 Torino, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH